Fontana Limited (FTNA) Releases Sep 2022 (Q1) Results – Sales, Profits & Cash Continue To Grow

The principal activity of the Company is the operation of a pharmacy business in each of its six locations

Here are the highlights.

This Quarter (2023Q1) vs Same Quarter Last Year

• Cash & Cash Equivalents was $1.35b vs $833.11m (61.68%)
  A huge cash balance ready to be deployed!
• Revenue of $1.64b vs $1.31b (25.76%)
  
• Net Income / Net Loss of $87.58m vs $61.13m (43.28%)
  Continues to recover from the pandemic-related challenges and benefit from improved international freight rates. Also saw a shift in the sales mix, with better growth from higher margin items such as stationery, during their best back-to-school sales season since the start of the pandemic
• Cash Flow From Operating Activities of -$62.70m vs $45.06m (-239.15%)
  They have more than doubled the amount spent on inventories compared to last year…both as things are back to normal and it is leading up to the  busy Christmas season. This increased spending was covered by their huge cash balance

How’s the stock doing?

• Share price: $8.99
• This Month: -1.43%
• This Year: +20.35%

This is just a summary. For more charts, ratios and other details visit FTNA’s page here